|
|
| WFDC1 / PS20 Antibody, Goat Polyclonal Antibody |
|
|
|
 |
| Catalog Number: 18-202-336194 |
|
|
 |
| Related Product Names:
|
-
WFDC1 antibody; WFDC1; PS20; WFDC1 / PS20 - WAP four-disulfide core domain 1; N/A |
 |
- Gene Information -
Information in yellow represents specific gene information and does not necessarily represent specific product details. For more information please contact sales@genwaybio.com.
|
 |
| Gene Name: WFDC1 |
Gene Name Synonym: PS20 |
Gi #:
18379353 |
NCBI Acc #:
NP_067020.2 |
Swiss Prot Acc #:
N/A |
Length (aa): 220 |
Mol. Weight (Da): N/A |
Chrom Location: N/A |
|
 |
Sequence: Peptide with sequence C-KNVAEPGRGQQKHFQ, from the C Terminus of the protein sequence according to NP_067020.2.
Notes: Peptide ELISA: antibody detection limit dilution 1:32,000. Western Blot: Preliminary experiments gave an approx 75kDa band in Human Liver, Placenta and Prostate lysates after 0.03ug/ml antibody staining. Please note that currently we cannot find an explanation in the literature for the band we observe given the calculated size of 23.9kDa according to NP_067020.2. The 75kDa band was successfully blocked by incubation with the immunizing peptide.
Source/Host: Goat
Purity/Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Clonality: Polyclonal
Crossreactivity: Human
Format: Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Storage: Aliquot and store at -20C
Shipping: Products may be shipped on ice pack or dry ice. |
 |
| APPLICATIONS for WFDC1 ANTIBODY: |
| E: Tested |
|
 |
|
 |
| WFDC1 ANTIBODY TARGET DESCRIPTION: |
Synonym Names for WFDC1 antibody: WFDC1; PS20; WAP four-disulfide core domain 1; N/A
Summary: This protein is a member of the WAP-type four disulfide core domain family. The WAP-type four-disulfide core domain, or WAP signature motif, contains eight cysteines forming four disulfide bonds at the core of the protein, and functions as a protease inhibitor in many family members. The encoded protein shares 81% amino acid identity with the rat ps20 protein, which was originally identified as a secreted growth inhibitor. This protein is mapped to chromosome 16q24, an area of frequent loss of heterozygosity in cancers, including prostate, breast and hepatocellular cancers and Wilms' tumor. Owing to its location and a possible growth inhibitory property of its gene product, this gene is suggested to be a tumor suppressor gene. [provided by RefSeq].
WFDC1 / PS20 reacts with human.
OMIM: NCBI [605322]
|
 |
|
SUGGESTED ANITBODY REAGENTS - GenWay has an extensive selection of reagents useful for antibody applications. Find blocking buffers, stop reagents, chemiluminescent substrates, diluents, Immunohistochemistry reagents & more.
|
 |
| BACKGROUND
REFERENCES for WFDC1 ANTIBODY: |
| Background references for antibody target are not specific to GenWay products |
[1] Madar,S., Brosh,R., Buganim,Y., Ezra,O., Goldstein,I., Solomon,H., Kogan,I., Goldfinger,N., Klocker,H. and Rotter,V. Modulated expression of WFDC1 during carcinogenesis and cellular senescence [2] Alvarez,R., Reading,J., King,D.F., Hayes,M., Easterbrook,P., Farzaneh,F., Ressler,S., Yang,F., Rowley,D. and Vyakarnam,A. WFDC1/ps20 is a novel innate immunomodulatory signature protein of human immunodeficiency virus (HIV)-permissive CD4+ CD45RO+ memory T cells that promotes infection by upregulating CD54 integrin expression and is elevated in HIV type 1 infection [3] Watson,J.E., Kamkar,S., James,K., Kowbel,D., Andaya,A., Paris,P.L., Simko,J., Carroll,P., McAlhany,S., Rowley,D. and Collins,C. Molecular analysis of WFDC1/ps20 gene in prostate cancer [4] McAlhany,S.J., Ressler,S.J., Larsen,M., Tuxhorn,J.A., Yang,F., Dang,T.D. and Rowley,D.R. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model [5] Saffroy,R., Riou,P., Soler,G., Azoulay,D., Emile,J.F., Debuire,B. and Lemoine,A. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma |
 |
Order Confirmation: Sales order confirmations are sent out upon the receipt of all orders. Please contact GenWay if you do not receive a confirmation within 1 business day of submitting your order.
Precautions: WFDC1 antibody is for in vitro research use only. Not for use in diagnostics or therapeutic procedures.
Important Notes: During shipment, small volumes of WFDC1 antibody vial. For products with volumes of 200 µL or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap. Actual concentration, volume and quantity will be printed on the vial's label. Please refer to the vials label for this information.
Copyright: This GenWay TDS is copyrighted. This datasheet is produced based partially on data from Swiss-Prot/TrEMBL and NCBI. To better serve our clients with everything we know about WFDC1 antibody, all related information, articles, resources about WFDC1 antibody are being stored on our online database. Let us know if you have questions regarding this product.
Disclaimer: For documents and software available from this server, GenWay neither warrants nor assumes any legal liability or responsibility for the accuracy, completeness or utility of any information, product or process disclosed. |
|
 |
|
GenWay is a Protein and Antibody Solutions Provider. Customer Satisfaction is Our Top Priority.
|
|
Thank you for visiting GenWay Biotech's Datasheet. GenWay is the world's leader in chicken, IgY antibody production, producing over 900 quality polyclonal IgY antibodies to date. From our unique recombinant protein production, utilizing a variety of protein expression systems, GenWay's polyclonal IgY antibodies incorporate more epitopes, increasing the success rate for ELISA, western blot, immunohistochemistry (IHC), immunocytochemistry (ICC), and many more immunoassays. |
|
|
|